Fengshen Kuo

Also affiliated with Kettering University

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 3%percentile

1.5Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

A multimodal atlas of tumour metabolism reveals the architecture of gene–metabolite covariation

Nature Metabolism(2023)10.1038/s42255-023-00817-8

Top 13%

1.5DataRank

Top 13%67 citations

Eric Minwei Liu, Cerise Tang, Fengshen Kuo, Mustafa Büyüközkan, Tricia Park +7 more

Papers

Driven by 39 papers — median percentile 87. Top paper: “Improved prediction of immune checkpoint blockade efficacy across multiple cancer types”.

Improved prediction of immune checkpoint blockade efficacy across multiple cancer types

Nature Biotechnology(2021)10.1038/s41587-021-01070-8

N/A

7.3DataRank · unranked

272 citations

Seong‐Keun Yoo, Cristina Valero, Alessandro Pastore, Chirag Krishna, Mark Lee +29 more

Comprehensive Genomic Analysis of Translocation Renal Cell Carcinoma Reveals Copy-Number Variations as Drivers of Disease Progression

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3283

N/A

1.9DataRank · unranked

55 citations

Renzo G. DiNatale, Alejandro Sánchez, Ritesh R. Kotecha, Sounak Gupta, Fengshen Kuo +18 more

A multimodal atlas of tumour metabolism reveals the architecture of gene–metabolite covariation

Nature Metabolism(2023)10.1038/s42255-023-00817-8

Top 13%

1.5DataRank

Top 13%67 citations

Eric Minwei Liu, Cerise Tang, Fengshen Kuo, Mustafa Büyüközkan, Tricia Park +7 more

Nivolumab plus ipilimumab in advanced salivary gland cancer: a phase 2 trial

Nature Medicine(2023)10.1038/s41591-023-02518-x

N/A

1.3DataRank · unranked

58 citations

Bharat Burman, Swati Jain, Conall Fitzgerald, Eric J. Sherman, Lara Dunn +24 more

Mutations in BRCA1 and BRCA2 differentially affect the tumor microenvironment and response to checkpoint blockade immunotherapy

Nature Cancer(2020)10.1038/s43018-020-00139-8

N/A

0.806DataRank · unranked

214 citations

Chirag Krishna, Xiaoxiao Ma, Xin Pei, Ken-Wing Lee, Vladimir Makarov +23 more

Precision Radiotherapy: Reduction in Radiation for Oropharyngeal Cancer in the 30 ROC Trial

JNCI Journal of the National Cancer Institute(2020)10.1093/jnci/djaa184

N/A

0.762DataRank · unranked

160 citations

Eric J. Sherman, Xin Pei, Heiko Schöder, Milan Grkovski, Ramesh Paudyal +38 more

Immunometabolic coevolution defines unique microenvironmental niches in ccRCC

Cell Metabolism(2023)10.1016/j.cmet.2023.06.005

N/A

0.483DataRank · unranked

24 citations

Amy Xie, Eric Minwei Liu, Fengshen Kuo, Min‐Soo Kim, Renzo G. DiNatale +15 more

Targeting the mTOR Pathway in Hurthle Cell Carcinoma Results in Potent Antitumor Activity

Molecular Cancer Therapeutics(2021)10.1158/1535-7163.mct-21-0224

N/A

0.396DataRank · unranked

13 citations

Yongxing Gong, Fengshen Kuo, Vladimir Makarov, Ed Reznik, Gouri J. Nanjangud +10 more

Phase 2 Trial of Regorafenib in Recurrent/Metastatic Adenoid Cystic Carcinoma

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-1064

N/A

0.344DataRank · unranked

7 citations

Joris L. Vos, Nora Katabi, Fengshen Kuo, Zaineb Nadeem, Maximilian Linxweiler +8 more

Gene expression of prostate-specific membrane antigen (FOLH1) in clear cell renal cell carcinoma predicts angiogenesis and response to tyrosine kinase inhibitors

Urologic Oncology Seminars and Original Investigations(2024)10.1016/j.urolonc.2024.10.013

N/A

0.331DataRank · unranked

6 citations

Marlon Perera, Nathan Papa, Fengshen Kuo, Mahdi Golkaram, Phillip M. Rappold +7 more

Determinants of sensitivity to HER2-targeted antibody drug conjugates in urothelial cancer

Nature Communications(2025)10.1038/s41467-025-67643-2

N/A

0.292DataRank · unranked

6 citations

Xinran Tang, Jordan Eichholz, Andrew McPherson, Jasmine Thomas, Karan Nagar +23 more

Characterizing the Immune Microenvironment and Neoantigen Landscape of Hürthle Cell Carcinoma to Identify Potential Immunologic Vulnerabilities

Cancer Research Communications(2023)10.1158/2767-9764.crc-23-0120

N/A

0.241DataRank · unranked

4 citations

Fengshen Kuo, Vladimir Makarov, Yiyu Dong, Ronald Ghossein, Bin Xu +3 more

Upper tract urothelial carcinoma transcriptome profiling and immune microenvironment characterization.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.564

N/A

0.165DataRank · unranked

2 citations

Kwanghee Kim, Fengshen Kuo, Andrew T. Lenis, Jie‐Fu Chen, Wenhuo Hu +15 more

Novel Genetic Subtypes of Urothelial Carcinoma With Differential Outcomes on Immune Checkpoint Blockade

Journal of Clinical Oncology(2023)10.1200/jco.22.02144

N/A

0DataRank · unranked

18 citations

Mahdi Golkaram, Samuel A. Funt, Hikmat Al‐Ahmadie, Shannon Kaplan, Fan Song +11 more

Genomic ancestry in kidney cancer: Correlations with clinical and molecular features

Cancer(2023)10.1002/cncr.35074

N/A

0DataRank · unranked

12 citations

Andrea Knežević, Kanika Arora, Chaitanya Bandlamudi, Fengshen Kuo, Maria I. Carlo +12 more

Patterns of immune equilibrium and escape in indolent and progressing tumors

Cancer Cell(2023)10.1016/j.ccell.2023.06.003

N/A

0DataRank · unranked

5 citations

Maximilian Linxweiler, Fengshen Kuo, Jennifer L. Marti, Benjamin R. Roman, Behfar Ehdaie +3 more

Data from The Immune Microenvironment and Neoantigen Landscape of Aggressive Salivary Gland Carcinomas Differ by Subtype

(2023)10.1158/1078-0432.c.6529017.v1

N/A

0DataRank · unranked

0 citations

Fengshen Kuo, Nora Katabi, Mark Lee, Zaineb Nadeem, Martin G. Dalin +11 more

Data from Associations between Pretreatment Body Composition Features and Clinical Outcomes among Patients with Metastatic Clear Cell Renal Cell Carcinoma Treated with Immune Checkpoint Blockade

(2023)10.1158/1078-0432.c.6532988.v1

N/A

0DataRank · unranked

0 citations

Alejandro Sánchez, Sujata Patil, Andrea Knežević, Emily Stein, Stacey Petruzella +15 more

Data from Associations between Pretreatment Body Composition Features and Clinical Outcomes among Patients with Metastatic Clear Cell Renal Cell Carcinoma Treated with Immune Checkpoint Blockade

(2023)10.1158/1078-0432.c.6532988

N/A

0DataRank · unranked

0 citations

Alejandro Sánchez, Sujata Patil, Andrea Knežević, Emily Stein, Stacey Petruzella +15 more

Data from Genomic and Transcriptomic Correlates of Thyroid Carcinoma Evolution after BRAF Inhibitor Therapy

(2023)10.1158/1541-7786.c.6545222.v1

N/A

0DataRank · unranked

0 citations

Brian R. Untch, Bin Xu, Ronald Ghossein, Catherine Y. Han, Fengshen Kuo +12 more

Tumor and blood B-cell abundance outperforms established immune checkpoint blockade response prediction signatures in head and neck cancer

Annals of Oncology(2024)10.1016/j.annonc.2024.11.008

N/A

0DataRank · unranked

22 citations

Aris Spathis, Alejandro A. Schäffer, N. Gavrielatou, Fengshen Kuo, Dongya Jia +19 more

Molecular Heterogeneity and Immune Infiltration Drive Clinical Outcomes in Upper Tract Urothelial Carcinoma

European Urology(2024)10.1016/j.eururo.2024.10.024

N/A

0DataRank · unranked

9 citations

Syed M. Alam, Fengshen Kuo, Ziyu Chen, Wesley Yip, Andrew Katims +34 more

Sample Site Impacts RNA Biomarkers for Renal Cell Carcinoma

European Urology(2024)10.1016/j.eururo.2024.09.004

N/A

0DataRank · unranked

4 citations

Amy Xie, Cerise Tang, Andrea Knežević, Irina Ostrovnaya, Fengshen Kuo +4 more

Prediction of checkpoint inhibitor immunotherapy efficacy for cancer using routine blood tests and clinical data

Nature Medicine(2025)10.1038/s41591-024-03398-5

N/A

0DataRank · unranked

111 citations

Conall Fitzgerald, Byuri Angela Cho, Bailey G. Fitzgerald, Catherine Y. Han, Elizabeth S. Koh +32 more

Loss of Kmt2c or Kmt2d primes urothelium for tumorigenesis and redistributes KMT2A–menin to bivalent promoters

Nature Genetics(2025)10.1038/s41588-024-02015-y

N/A

0DataRank · unranked

17 citations

Mohini R. Pachai, Dan Li, Cindy J. Lee, Sarah Warda, Makhzuna N. Khudoynazarova +25 more

Immune Checkpoint Blockade Response in Mucinous Tubular and Spindle Cell Carcinoma

Current Oncology(2025)10.3390/curroncol32020094

N/A

0DataRank · unranked

1 citations

Neil J. Shah, Maria I. Carlo, Fengshen Kuo, A. Ari Hakimi, Ying‐Bei Chen +3 more

Intratumoral early activated TCF1+ CD4 Th cells drive effector CD8 T cell responses in a novel sarcomatoid RCC model through anti-CTLA4 therapy 3951

The Journal of Immunology(2025)10.1093/jimmun/vkaf283.1692

N/A

0DataRank · unranked

0 citations

Lynda Vuong, Fengshen Kuo, Doris Zheng, Alex Penson, Jing Zhang +15 more

TGF-β suppresses type 2 immunity to cancer

Nature(2020)10.1038/s41586-020-2836-1

N/A

0DataRank · unranked

189 citations

Fengshen Kuo, Kristelle J. Capistrano, Davina Kang, Briana G. Nixon, Wei Shi +11 more

The Immune Microenvironment and Neoantigen Landscape of Aggressive Salivary Gland Carcinomas Differ by Subtype

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3758

N/A

0DataRank · unranked

126 citations

Fengshen Kuo, Nora Katabi, Mark Lee, Zaineb Nadeem, Martin G. Dalin +11 more

A pan-cancer analysis of PBAF complex mutations and their association with immunotherapy response

Nature Communications(2020)10.1038/s41467-020-17965-0

N/A

0DataRank · unranked

66 citations

Kyrollis Attalla, Renzo G. DiNatale, Irina Ostrovnaya, Jessica Flynn, Kyle A. Blum +12 more

IRF8 Governs Tumor-Associated Macrophage Control of T Cell Exhaustion

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.03.12.989731

N/A

0DataRank · unranked

4 citations

Fengshen Kuo, Ming Liu, Kristelle J. Capistrano, Mytrang Do, Ruth A. Franklin +15 more

TGFβ Suppresses Type 2 Immunity to Cancer

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.03.04.977629

N/A

0DataRank · unranked

0 citations

Fengshen Kuo, Kristelle J. Capistrano, Davina Kang, Briana G. Nixon, Wei Shi +11 more

Single-cell sequencing links multiregional immune landscapes and tissue-resident T cells in ccRCC to tumor topology and therapy efficacy

Cancer Cell(2021)10.1016/j.ccell.2021.03.007

N/A

0DataRank · unranked

444 citations

Renzo G. DiNatale, Fengshen Kuo, Raghvendra M. Srivastava, Lynda Vuong, Diego Chowell +28 more

Genomic and Transcriptomic Correlates of Thyroid Carcinoma Evolution after BRAF Inhibitor Therapy

Molecular Cancer Research(2021)10.1158/1541-7786.mcr-21-0442

N/A

0DataRank · unranked

20 citations

Brian R. Untch, Bin Xu, Ronald Ghossein, Catherine Han, Fengshen Kuo +12 more

Functional landscapes of POLE and POLD1 mutations in checkpoint blockade-dependent antitumor immunity

Nature Genetics(2022)10.1038/s41588-022-01108-w

N/A

0DataRank · unranked

79 citations

Nadeem Riaz, Robert Samstein, Mark Lee, Vladimir Makarov, Cristina Valero +29 more

A Targetable Myeloid Inflammatory State Governs Disease Recurrence in Clear-Cell Renal Cell Carcinoma

Cancer Discovery(2022)10.1158/2159-8290.cd-21-0925

N/A

0DataRank · unranked

33 citations

Lynda Vuong, Josef Leibold, Nicholas H. Chakiryan, Michael Curry, Fengshen Kuo +31 more

A robust, trial-agnostic gene signature for response to tyrosine kinase inhibition in ccRRCC.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.4558

N/A

0DataRank · unranked

0 citations

Minwei Liu, Fengshen Kuo, Ritesh R. Kotecha, Chung‐Han Lee, Martin H. Voss +4 more

Activation of the EGFR / PI3K / AKT pathway limits the efficacy of trametinib treatment in head and neck cancer

Molecular Oncology(2023)10.1002/1878-0261.13500

N/A

0DataRank · unranked

34 citations

Avital Beeri Shnerb, Divyasree Marripati, Sankar Jagadeeshan, Raghda Abu Shareb, Cristina Conde‐López +13 more

Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-2882

N/A

0DataRank · unranked

34 citations

Mahesh Saqcena, Fengshen Kuo, Ravinder K. Grewal, Nicholas D. Socci, Jeffrey A. Knauf +8 more

Fengshen Kuo

Indexed papers

Top data-sharing exemplar

Papers